Head and neck cancers account for less than 5% of all cancers and for less than 3% of all
cancer deaths in the United States. The populations at risk for head and neck cancers are …

The multidisciplinary approach to treating squamous cell carcinoma of the head and neck is
complex and evolving. This article aims to review some recent developments in squamous …

Head and neck cancer is a challenging disease that is expected to account for greater than
500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy …

The management of head and neck cancer in recent years has involved increasingly
complex, combined-modality programs, as well as the integration of new diagnostic and …

Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck
region. The risk factors for development of cancers of the oral cavity, oropharynx …

Despite the development of standard therapies, including surgery, radiotherapy and
chemotherapy, survival rates for head and neck squamous cell carcinoma (HNSCC) have …

Historically treatment of head and neck cancers involved surgical resection followed by
radiation therapy for advanced tumors. Concurrent chemoradiation therapies have shown …

Head and Neck Cancer Most head and neck cancers (73% in the United States) are now
related to human papillomavirus infection rather than tobacco and alcohol. Primary cancers …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin
cancer with a tobacco consumption and infection with high-risk human papillomavirus (HPV) …

Simple Summary The mainstay of treatment for locoregionally advanced head and neck
squamous cell carcinoma (HNSCC) is either surgery followed by adjuvant radiation therapy …